Skip to Main Content

National Coverage Analysis (NCA) for Aprepitant for Chemotherapy-Induced Emesis (CAG-00248R)

Expand/collapse the Contacts section

Contact(s)

Cheryl Gilbreath, PharmD, MBA, R.Ph

Cheryl.gilbreath@cms.hhs.gov

410-786-5919

Back to Top

Expand/collapse the Documents section

Documents

Tracking Sheet

Proposed Decision Memo

View Public Comments

NCD for Aprepitant for Chemotherapy-Induced Emesis (110.18)

Back to Top

Expand/collapse the History of Considerations section

History of Considerations

Original Consideration for Aprepitant for Chemotherapy-Induced Emesis (CAG-00248N)

First reconsideration for Aprepitant for Chemotherapy-Induced Emesis (this document)

Back to Top

Footer Links

www